P450-Catalyzed Biaryl Macrocyclization of Leaderless Ribosomal Peptides
Runze Liu,Hongyu Ren,Gengfan Wu,Beibei He,Cuiping Pang,Zhuanglin Shen,Jing Liu,Song Zhiman,Jiahai Zhou,Yong-xin Li
DOI: https://doi.org/10.1101/2024.10.06.616194
2024-10-06
Abstract:Macrocyclic peptides, an intriguing class of molecules, embody promising frameworks for the development of chemical probes and prospective therapeutic agents. However, the lack of an established wide-substrate scope synthesis methodology has made it challenging to achieve both efficiency and selectivity simultaneously. P450-catalyzed ribosomal synthesized and post-translational modification peptides (RiPPs) are a new family of macrocyclic peptides with typical biaryl crosslinks. In this study, we report the discovery of a RiPP-modified P450 macrocyclase, GpeC, which natively catalyzes the biaryl C(sp2)-C(sp2) crosslink of tryptophan-tyrosine in a tetrapeptide module. Unlike most previously documented P450-RiPPs that possess a substantial leader peptide region, hindering biocatalytic applications, our P450 GpeC exhibits catalytic potential with leaderless precursor peptides and a wide substrate tolerance, highlighting its adaptability and potential for creating diverse macrocyclic structures. The crystal structure of GpeC, combined with in silico calculations and site-directed mutagenesis, provides strong evidence for the extreme flexibility of intra-cyclic amino acids within the biaryl-cyclized tetrapeptide. This flexibility enables the substitution of any of the other 19 amino acids, indicating that GpeC is a robust and adaptable catalyst for biaryl cyclization, providing a valuable resource for the biocatalytic synthesis of complex macrocyclic compounds.
Biochemistry